Skip to main content

Advertisement

SpringerLink
Log in

Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence

  • Critical Perspectives
  • Published:
Journal of Bioethical Inquiry Aims and scope Submit manuscript

Abstract

Different immunotherapeutic approaches are in the pipeline for the treatment of drug dependence. “Drug vaccines” aim to induce the immune system to produce antibodies that bind to drugs and prevent them from inducing rewarding effects in the brain. Drugs of abuse currently being tested using these new approaches are opioids, nicotine, cocaine, and methamphetamine. In human clinical trials, “cocaine and nicotine vaccines” have been shown to induce sufficient antibody levels while producing few side effects. Studies in humans, determining how these vaccines interact in combination with their target drug, are underway. However, although vaccines can become a reasonable treatment option for drugs of abuse, there are several disadvantages that must be considered. These include i) great individual variability in the formation of antibodies, ii) the lack of protection against a structurally dissimilar drug that produces the same effects as the drug of choice, and iii) the lack of an effect on the drug desire that may predispose an addict to relapse. In addition, a comprehensive overview of several crucial ethical issues has not yet been widely discussed in order to have not only a biological approach to immunotherapy of addiction. Overall, immunotherapy offers a range of possible treatment options: the pharmacological treatment of addiction, the treatment of overdoses, the prevention of toxicity to the brain or the heart, and the protection of the fetus during pregnancy. So far, the results obtained from a small-scale experiment using vaccines against cocaine and nicotine suggest that a number of important technical challenges still need to be overcome before such vaccines can be approved for clinical use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akbarzadeh, A., M. Mehraby, M. Zarbakhsh, and H. Farzaneh. 1999. Design and synthesis of a morphine-6-succinyl-bovine serum albumin hapten for vaccine development. Biotechnology and Applied Biochemistry 30(2): 139–145.

    CAS  PubMed  Google Scholar 

  • Akbarzadeh, A., D. Norousian, A. Farhangi, et al. 2009. Immunotherapy of 347 volunteer outpatient morphine addicts by human therapeutic morphine vaccine in Kermanshah. Journal of Pharmacology and Toxicology 4: 30–35.

    Article  CAS  Google Scholar 

  • Alving, C.R., G.R. Matyas, O. Torres, R. Jalah, and Z. Beck. 2014. Adjuvants for vaccines to drugs of abuse and addiction. Vaccine 32(42): 5382–5389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anton, B., and P. Leff. 2006. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 24(16): 3232–3240.

    Article  CAS  PubMed  Google Scholar 

  • Anton, B., A. Salazar, A. Flores, et al. 2009. Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Human Vaccines 5(4): 214–229.

    Article  CAS  PubMed  Google Scholar 

  • Ashcroft, R E., and C. Franey. 2004. Further ethical and social issues in using a cocaine vaccine: Response to Hall and Carter. Journal of Medical Ethics 30: 341–343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baird, T.J., S.X. Deng, D.W. Landry, G. Winger, and J.H. Woods. 2000. Natural and artificial enzymes against cocaine I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. Pharmacology and Experimental Therapeutics 295(3): 1127–1134.

    CAS  Google Scholar 

  • Berkowitz, B., and S. Spector. 1972. Evidence for active immunity to morphine in mice. Science 178(67): 1290–1292.

    Article  CAS  PubMed  Google Scholar 

  • Bonese, K.F., B.H. Wainer, F.W. Fitch, R.M. Rothberg, and C.R. Schuster. 1974. Changes in heroin self- administration by a rhesus monkey after morphine immunisation. Nature 252(5485): 708–710.

    Article  CAS  PubMed  Google Scholar 

  • Bremer P.T., A. Kimishima, J. E. Schlosburg, B. Zhou, K.C. Collins, K. D. Janda. 2016. Combatting synthetic designer opioids: A conjugate vaccine ablates lethal doses of fentanyl class drugs. Angewandte Chemie International Edition 55(11): 3772–3775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brimijoin, S., F. Orson, T. Kosten, et al. 2013a. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. Chemico-Biological Interactions 203(1): 212–216.

    Article  CAS  PubMed  Google Scholar 

  • Brimijoin, S., X. Shen, F. Orson, and T. Kosten. 2013b. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse. Expert Review of Vaccines 12(3): 323–332.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Byrnes-Blake, K., F. Carroll, P. Abraham, and S. Owens. 2001. Generation of anti-(+) methamphetamine antibodies is not impeded by (+) meth-amphetamine administration during active immunization of rats. International Immunopharmacology 1(2): 329–338.

    Article  CAS  PubMed  Google Scholar 

  • Carrera, M.R.A., J.A. Ashley, L.H. Parsons, P. Wisching, G. Koob, and K.D. Janda. 1995. Suppression of psychoactive effects of cocaine by active immunization. Nature 378(6558): 727–730.

    Article  CAS  PubMed  Google Scholar 

  • Carrera, M.R., J.M. Trigo, P. Wirsching, et al. 2005. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Pharmacology biochemistry and behavior 81(4): 709–714.

    Article  CAS  Google Scholar 

  • Carroll, F., P. Abraham, P. Gong, et al. 2009. The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse. Journal of Medicinal Chemistry 52(22): 7301–7309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carroll, M.E., N.E. Zlebnik, J.J. Andker, et al. 2012. Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion. PPLoS ONE 7(8): e43536.

    Article  CAS  Google Scholar 

  • Cheng, L., S. Kim, A. Chung, and A. Castro. 1973. Amphetamines: new radioimmunoassay. FEBS Letters 36(3): 339–342.

    Article  CAS  PubMed  Google Scholar 

  • Choi, M., B. Gorovitz, J. Choi, E. Song, K. Nam, and J. Park. 1994. A visual immunoassay for the detection of methamphetamine using an enzyme labeled tracer derived from methamphetamine and amphetamine. Biological and Pharmaceutical Bulletin 17(7): 875–880.

    Article  CAS  PubMed  Google Scholar 

  • Choi, J., M. Choi, C. Kim, Y. Cho, J. Chin, and Y. Joi. 1997. The optimization of ELISA for methamphetamine determination: The effect of immunogen, tracer and antibody purification method on the sensitivity. Archives of Pharmacal Research 20(1): 46–52.

    Article  CAS  PubMed  Google Scholar 

  • Choi, J., C. Kim, and M. Choi. 1998. Immunological analysis of methamphetamine antibody and its use for the detection of methamphetamine by capillary electrophoresis with laser-induced fluorescence. Journal of Chromatography B 705(2): 277–282.

    Article  CAS  Google Scholar 

  • Christakis, N.A., and J.H. Fowler. 2009. The surprising power of our social networks and how they shape our lives - How your friends’ friends’ friends affect everything you feel, think, and do. Little, Brown and Co. Hachette Book Group: New York.

    Google Scholar 

  • Clinical Trials 2006. NicVAX® (Nicotine Conjugate Vaccine). https://clinicaltrials.gov/ct2/show/NCT00318383. Accessed 10 February, 2017.

  • Cohen, P.J. 1997. Immunization for prevention and treatment of cocaine abuse: Legal and ethical implication. Drug and Alcohol Dependence 48(3): 167–174.

    Article  CAS  PubMed  Google Scholar 

  • Cohen, P. 2000. No more kicks. New Scientist 166(2242): 23–36.

    Google Scholar 

  • Ersche, K., P.S. Jones, G.B. Williams, A.J. Turton, T.W. Robbins, and E.T. Bullmore. 2012. Abnormal brain structure implicated in stimulant drug addiction. Science 335(6068): 601–604.

    Article  CAS  PubMed  Google Scholar 

  • European Medicines Agency, EMA. 2004. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003809.pdf . Accessed February 10, 2017.

  • Farhangi, A., A. Akbarzadeh, M. Mehrabi, et al. 2012. Immunotherapy of 436 morphine addicts by design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse. Journal of Pharmacology and Experimental Therapeutics 322: 30–39.

    Google Scholar 

  • Friedman H., S. Pross, and T.W. Klein. 2006. Addictive drugs and their relationship with infectious diseases. FEMS Immunology and Medical Microbiology 47(3): 330–42.

    Article  CAS  PubMed  Google Scholar 

  • Fox, B.S., K.M. Kantak, M.A. Edwards, et al. 1996. Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Medicine 2(10): 1129–1132.

    Article  CAS  PubMed  Google Scholar 

  • Hall, W. 2007. A research agenda for assessing the potential contribution of genomic medicine to tobacco control. Tobacco Control 16(1): 53–58.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hall, W., and L. Carter. 2004. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. Journal of Medical Ethics 30(4): 337–340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hall, W., and C. Gartner. 2011. Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependence. Current Opinion in Psychiatry 24(3): 191–196.

    Article  PubMed  Google Scholar 

  • Hartmann-Boyce, J., K. Cahill, D. Hatsukami, and J. Cornuz. 2012. Nicotine vaccines for smoking cessation. Cochrane Database of Systematic Reviews 15(8): CD007072.

    Google Scholar 

  • Hasman, A., and S. Holm. 2004. Nicotine conjugate vaccine: Is there a right to a smoking future? Journal of Medical Ethics 30(4): 344–345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hubbard, J.J., E.M. Laurenzana, D.K. Williams, W.B. Gentry, and S.M. Owens. 2011. Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats. International Immunopharmacology 11(12): 2181–2187.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hyman, S.E. 2007. The neurobiology of addiction: Implications for voluntary control of behavior. American Journal of Bioethics 7(1): 8–11.

    Article  PubMed  Google Scholar 

  • Jalah, R., O.B. Torres, A.V. Mayorov, et al. 2015. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Bioconjugate Chemistry 26(6): 1041–1053.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson, M.W., and R.H. Ettinger. 2000. Active cocaine immunization attenuates the discriminative properties of cocaine. Experimental and Clinical Psychopharmacology 8(2): 163–167.

    Article  CAS  PubMed  Google Scholar 

  • Kaebnick, G.E. 2000. Vaccinations against bad habits. Hastings Center Report 30(5): 48.

    Google Scholar 

  • Kantak, K., S. Collins, E. Lipman, J. Bond, K. Giovanoni, and B.S. Fox. 2000. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology 148(3): 251–262.

    Article  CAS  PubMed  Google Scholar 

  • Kantak, K.M. 2003. Vaccines against drugs of abuse. Drugs 63(4): 341–352.

    Article  CAS  PubMed  Google Scholar 

  • Katsnelson, A. 2004. Ethical quagmire awaits vaccine for cocaine addiction. Nature Medicine 10: 1007.

    Article  CAS  PubMed  Google Scholar 

  • Keyler, D.E., D. Soeman, M.G. LeSage, et al. 2003. Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats. The Journal of Pharmacology and Experimental Therapy 305(2): 587–592.

    Article  CAS  Google Scholar 

  • Kinsey, B. 2014. Vaccines against drugs of abuse: Where are we now? Therapeutic Advances in Vaccines 2(4): 106–117.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kosten, T., M. Rosen, J. Bond, et al. 2002. Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine 20(7): 1196–1204.

    Article  CAS  PubMed  Google Scholar 

  • Kosten, T., and S.M. Owens. 2005. Immunotherapy for the treatment of drug abuse. Pharmacology & Therapeutics 108(1): 76–85.

    Article  CAS  Google Scholar 

  • Kosten, T., C. Domingo, D. Shorter, et al. 2014a. Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial. Drug and Alcohol Dependence 140: 42–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kosten, T., C. Domingo, F. Orson, and B. Kinsey. 2014b. Vaccines against stimulants: Cocaine and MA. British Journal of Clinical Pharmacology 77(2): 368–374.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Landsteiner, K. 1945. The specificity of serological reactions, revised ed. New York: Dover.

  • Leukefeld, C.G., and F.M. Tims. 1988. Compulsory treatment: A review of the findings. In Compulsory treatment of drug abuse: Research and clinical practice, edited by C.G. Leukefeld and F.M. Tims, 236–254. NIDA Monograph No 86. Rockville, MD: NIDA.

  • Leshner, A.I. 1997. Addiction is a brain disease, and it matters. Science 278(5335): 45–47.

    Article  CAS  PubMed  Google Scholar 

  • Li Q.Q., Y.X. Luo, C.Y. Sun, et al. 2011. A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. Journal of Neurochemistry 119(6): 1271–1281.

    Article  CAS  PubMed  Google Scholar 

  • Martell, B.A., E. Mitchell, J. Poling, K. Gonsai, and T.R. Kosten. 2005. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biological Psychiatry 58(2): 158–164.

    Article  CAS  PubMed  Google Scholar 

  • Martell, B., F. Orson, and J. Poling. 2009. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Archives of General Psychiatry 66(10): 1116–1123.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maurer, P., and M.F. Bachmann. 2007. Vaccination against nicotine: An emerging therapy for tobacco dependence. Expert Opinion Investigational Drugs. 16(11): 1775–1783.

    CAS  Google Scholar 

  • Mets B., G. Winder, C. Cabrera, et al. 1998. A catalytic antibody against cocaine prevents cocaine’s reinforcing and toxic effects in rats. Proceedings of the National Academy of Science 95(17): 10176–10181.

    Article  CAS  Google Scholar 

  • Mettens P., and P. Monteyne. 2002. Life-style vaccines. British Medical Bulletin 62(1): 175–86.

    Article  PubMed  Google Scholar 

  • Miller, M., A. Moreno, S. Aarde, et al. 2013. A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. Biological Psychiatry 73(8): 721–728.

    Article  CAS  PubMed  Google Scholar 

  • Miller, M.L., S.M. Aarde, A.Y. Moreno, K.M. Creehan, K.D. Janda, and M.A. Taffe. 2015. Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats. Drug and Alcohol Dependence 153: 29–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moreno A.Y., A.V. Mayorov, and K.D. Janda. 2011. The impact of distinct chemical structures for the development of a methamphetamine vaccine. Journal of the American Chemical Society 133(17): 6587–6595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • National Research Council. 2001. Informing America’s policy on illegal drugs: What we don’t know keeps hurting us. Washington: National Academy Press.

    Google Scholar 

  • Nielsen, D.A., S.C. Hamon, and T.R. Kosten. 2013. κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatric Genetics 23(6): 1–14.

    Article  Google Scholar 

  • Norman, A.B., and W.J. Ball Jr. 2012. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody. Immunotherapy 4(3): 335–343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Osburn, A. 2008. Immunizing against addiction: The argument for incorporating emerging anti-addiction vaccines into existing compulsory immunization statutes. Cleveland State Law Review 56: 159–188.

    Google Scholar 

  • Owens, S., W. Atchley, M. Hambuchen, E. Peterson, and W. Gentry. 2011. Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction. CNS & Neurological Disorders - Drug Targets 10: 892–898.

    Article  CAS  Google Scholar 

  • Pompidou Group. 2010. Experts committee on ethical issues and professional standards. Ethical questions raised by immunotherapy of addiction. Olivier Simon. Appendix A. 16–22. https://www.coe.int/T/DG3/Pompidou/Source/Files/minconf/P-PG-Ethics-2010-11-en.pdf. Accessed 10 February, 2017

  • Porter, L., A. Arif, and W. Curran. 1986. The law and the treatment of drug and alcohol dependent person: A comparative study of existing legislation. Geneva: World Health Organization.

    Google Scholar 

  • Pravetoni M.., M.D. Raleigh, M. Le Naour, et al. 2012. Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine 30(31): 4617–4624.

  • Ryan, J., C. Parker, and R. Williams. 1972. Gamma-Globulin binding of morphine in heroin addicts. Journal of Laboratory and Clinical Medicine 80(2): 155–184.

    CAS  PubMed  Google Scholar 

  • Shen, X.Y., F.M. Orson, and T.R. Kosten. 2012. Vaccines against drug abuse. Clinical Pharmacology & Therapeutics 91(1): 60–70.

    Article  CAS  Google Scholar 

  • Shen, X., T. Kosten, A. B. Lopez, et al. 2013. A vaccine against methamphetamine attenuates its behavioral effects in mice. Drug and Alcohol Dependence 129(1): 41–48.

    Article  CAS  PubMed  Google Scholar 

  • Spector, S and C. Parker. 1970. Morphine: Radioimmunoassay. Science 168(3937): 1347–1348.

    Article  CAS  PubMed  Google Scholar 

  • Spooner C., W. Hall, and R.P. Mattick. 2001. An overview of diversion strategies for Australian drug-related offenders. Drug and Alcohol Review 20(3): 281–294.

    Article  Google Scholar 

  • Stevens, M.W., R.L. Henry, S.M. Owens, R. Schutz, and W. B. Gentry. 2014. First human study of a chimeric antimethamphetamine monoclonal antibody in healthy volunteers. mAbs 6: 1649–1656.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stowe G.N., J.E. Schlosburg, L.F. Vendruscolo, et al. 2011. Developing a vaccine against multiple psychoactive targets: A case study of heroin. CNS & Neurological Disorders - Drug Targets, 10 (B): 865–875.

    Article  CAS  Google Scholar 

  • Szatz, T. 1997. Ceremonial chemistry: The ritual persecution of drugs, addicts, and pushers, revised ed. Holmes Beach, FL: Learning Publications.

    Google Scholar 

  • Treweek, J.B., and K.D. Janda. 2012. An antidote for acute cocaine toxicity. Molecular Pharmaceutics 9(4): 969–978.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • UNODC. World Drug Report. 2016. United Nations publication.https://www.coe.int/T/DG3/Pompidou/Source/Files/minconf/P-PG-Ethics-2010-11-en.pdf unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf. Accessed 14 November 2017.

  • Wagena E.J., A. de Vos, G. Horwith, and C.P. van Schayck. 2008. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1/2 trial. Nicotine Tobacco Research. 10(1): 213–218.

    Article  CAS  Google Scholar 

  • World Medical Association 2013. Declaration of Helsinki: Ethical principles for medical research involving human subjects. 64th WMA General Assembly, Fortaleza, Brazil.

    Google Scholar 

  • Young M.J., D.A. Sisti, H. Rimon-Greenspan, J.L. Schwartz and A.L. Caplan. 2012. Immune to addiction: The ethical dimensions of vaccines against substance abuse. Nature Immunology 13(6): 521–524.

    Article  CAS  PubMed  Google Scholar 

  • Volkow N.D., and T.K. Li. 2004. Drug addiction: The neurobiology of behaviour gone awry. Nature Reviews Neuroscience 5(12): 963–70.

    Article  CAS  PubMed  Google Scholar 

  • Zalewska-Kaszubska, J. 2015. Is immunotherapy an opportunity for effective treatment of drug addiction? Vaccine 33: 6545–6551.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Forensic Toxicology Unit, Section of Legal Medicine, Università degli Studi della Campania “L. Vanvitelli”, Via L. Armanni, 5, 80138, Naples, Italy

    Anna Carfora, Paola Cassandro, Francesco La Sala, Raffaella Petrella & Renata Borriello

  2. Department of Biomedicine and Prevention, Università degli Studi di Roma “Tor Vergata”, Via Montpellier, 1, 00133, Rome, Italy

    Alessandro Feola

Authors
  1. Anna Carfora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Cassandro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Feola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco La Sala
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raffaella Petrella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renata Borriello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Carfora.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carfora, A., Cassandro, P., Feola, A. et al. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence. Bioethical Inquiry 15, 45–55 (2018). https://doi.org/10.1007/s11673-017-9834-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11673-017-9834-5

Keywords

Search

Navigation